Physiopathology and improvement of the saphenous vein graft in coronary artery bypass graft
JG Lobo Filho, MD Pimentel… - European Journal of …, 2023 - academic.oup.com
We read with great interest the study by Stevens et al.[1], in which, in a randomized non-
inferiority trial (AMI-PONT trial), the authors compared 2 strategies for revascularization of …
inferiority trial (AMI-PONT trial), the authors compared 2 strategies for revascularization of …
The Controversy of Using Insufficient Great Saphenous Veins in Coronary Artery Bypass Grafting: A Comparative Morphological Analysis of Healthy and Insufficient …
AF Părău, AR Manzur, S Mihaicuta, IA Petrache - Biomedicines, 2024 - mdpi.com
Background: Despite advancements in coronary artery bypass grafting (CABG), the optimal
choice of graft material remains a subject of investigation. This study aimed to …
choice of graft material remains a subject of investigation. This study aimed to …
“No-touch” Saphenous Vein Grafts for Coronary Artery Bypass Grafting
H Tsuneyoshi - Journal of Coronary Artery Disease, 2023 - jstage.jst.go.jp
Although saphenous vein grafts (SVGs) are used worldwide as bypass conduits, the long-
term graft patency of an SVG is unfavorable compared to that of arterial grafts. Therefore …
term graft patency of an SVG is unfavorable compared to that of arterial grafts. Therefore …
A Novel Marker Triglyceride Glucose Index in Predicting the Development of No-reflow in Acute Coronary Syndrome without ST-segment Elevation.
M Altunova, M Koseoglu - Medical Bulletin of Haseki/Haseki …, 2024 - search.ebscohost.com
Abstract Aim: The triglyceride-glucose (TyG) index is a new marker that predicts adverse
clinical outcomes in coronary artery disease. We aimed to investigate the relationship …
clinical outcomes in coronary artery disease. We aimed to investigate the relationship …